In tumor therapy, the enhanced permeability and retention (EPR) effect allows nanoparticles to passively accumulate more efficiently in tumor tissues, making them ideal carriers for delivering proinflammatory cytokines such as IL-2, IL-12, and TNFα (82). The gene discussed is IL2; the disease is neoplasm.